spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  i-FACTOR 

 HSMN NewsFeed - 29 Apr 2021
Cerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 1 Apr 2021
SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 5 Nov 2020
Cerapedics Announces Commercial Launch of i-FACTOR(R)+ Matrix in Canada
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 22 Jul 2020
Cerapedics Announces FDA approval of an IDE supplement
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 5 Mar 2020
New Data Demonstrates Andexxa(R) Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2019
Cerapedics Appoints Patrick O'Connor as Vice President of Clinical and Market Development
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 16 Jul 2018
Cerapedics Announces Closing of $22 Million Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 2 Apr 2018
Endo Agrees to Extend Temporary Stay of FDA Litigation
Biopharmaceuticals FDA Litigation
 HSMN NewsFeed - 26 Mar 2018
Pythagoras Medical Receives CE-Mark for the ConfidenHT(TM) System
Devices Cardiology Regulatory
 HSMN NewsFeed - 14 Mar 2018
Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
Devices Orthopaedic FDA
 HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jan 2018
Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2016
Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4(TM) Study of Factor Xa Inhibitor Antidote AndexXa(TM) (andexanet alfa) in Patients with Acute Major Bleeding
Biopharmaceuticals
 HSMN NewsFeed - 26 Aug 2016
Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA(TM)-4 Study of AndexXa(TM) (andexanet alfa) at European Society of Cardiology 2016 Congress
Biopharmaceuticals
 HSMN NewsFeed - 19 Aug 2016
Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) for IndexXa(TM) (andexanet alfa), a Factor Xa Inhibitor Antidote
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Aug 2016
Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa(TM) (andexanet alfa)
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2016
Cerapedics Announces Publication of Results from Pivotal IDE Clinical Trial of i-FACTOR(TM) Bone Graft in the Cervical Spine
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 7 Jan 2016
BioLight Reports Positive Second Clinical Study Results for its TeaRx(TM) Multi-Assay Test for Dry Eye Syndrome
Diagnostics Ophthalmology
 HSMN NewsFeed - 3 Nov 2015
Cerapedics Receives FDA Approval for i-FACTOR(TM) Peptide Enhanced Bone Graft in Cervical Spine Surgery
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2015
Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR(TM) PMA Approval
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Jan 2014
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 17 Apr 2012
ThromboGenics Resubmits BLA for Ocriplasmin With the FDA
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Sep 2011
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2011
Pulmatrix Promotes Robert Clarke, PhD, to Chief Scientific Officer and Vice President of Research and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Sep 2010
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Aug 2010
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2010
Cerapedics, Inc. Receives CE Mark for i-FACTOR Flex Bone Graft
Devices Regulatory
 HSMN NewsFeed - 17 May 2010
Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2009
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
Diagnostics Licensing
 HSMN NewsFeed - 6 Apr 2009
Cerapedics Closes $15 Million Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Aug 2008
ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2007
ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Mar 2007
Molnlycke Adds Sterile Exam Glove to Biogel(R) Glove Line
Devices
 HSMN NewsFeed - 25 Nov 2006
AMICAS Debuts RadStream(TM), a Pioneering Workflow Solution Proven to Improve Radiology Productivity, Service and Quality
Devices Radiology
 HSMN NewsFeed - 18 May 2006
IntegraGen Appoints Jorg Leenings as Head of Sales and Marketing of its German Competence Centre for Genetic Diabetes Testing
Diagnostics Personnel
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
i-FACTOR
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.